Safety Issues
Conditions
Keywords
driving, propofol sedation, colonoscopy
Brief summary
This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely after outpatient colonoscopy.
Detailed description
The hospital policy of routine discharge to normal activity 1 hour after propofol mono-sedation for EGD or colonoscopy was approved by the ethics committee of Showa Inan General Hospital in January, 2004 (http://www.sihp.jp). The investigator' s subsequent experience verified the safety of this discharge policy which was reconfirmed in March 2014. Based on these studies, the upper limit of 200 mg was established for those allowed early discharge and driving to home. This study examines that the use of \>200 mg of propofol sedation enables patients to drive home safely 90-120 minutes after outpatient colonoscopy.
Interventions
DRUGPropofol
Using \> 200 mg of propofol sedation colonoscopy is performed. 90-120 minutes after colonoscopy subjects go home. Within 1 week patients will be asked about their condition and satisfaction for colonoscopy.
Sponsors
Showa Inan General Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* subjects who drive home by theirselves after colonoscopy using propofol sedation (\>200 mg)
Exclusion criteria
* Subjects who received emergency procedures * less than 20 years old pregnant American Society of Anesthesiologists (ASA) class III or IV, overweight (body weight \>100 kg) allergic to the drugs used or its components (soybeans or eggs).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Traffic accidents | 1 day | Number of traffic accidents |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient satisfaction | 1 day | Patient satisfaction (bad, 0-good 100%) is asked. |
Countries
Japan
Outcome results
None listed